Adaptive immune mechanism in acute H. pylori infection

急性幽门螺杆菌感染的适应性免疫机制

基本信息

  • 批准号:
    7252129
  • 负责人:
  • 金额:
    $ 13.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-15 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

Helicobacter pylori is a highly adaptive pathogen that escapes host bacterial defenses (i.e., gastric acid and humoral immunity) leading to chronic infection. The broad, long-term objective of this proposal is to elucidate the factors contributing to the failure of the initial host immune response to eradicate H. pylori. The specific hypothesis behind the proposed research is that a defective DC-dependent adaptive immune mechanism against acute H. pylori infection leads to a failure to eradicate H. pylori. This hypothesis is based on the following observations. First, DCs are the most potent antigen presenting cells (APCs) that upon activation can migrate to secondary lymphoid organs to prime an adaptive T cell response. Second, many studies have implicated the involvement of DCs in the pathogenesis/response to a variety of intestinal bacterial pathogens. Third, a type 1 T helper (Th1) response, induced by APCs, has recently been shown to be crucial for vaccine-induced protection against H. pylori. The specific aims are to: 1. Determine the time course of DC recruitment from blood to H. pylori infected stomach and the role of CCR2 and its ligand, MCP-1, in DC recruitment. Transgenic CD11cp-DTR-GFP C57BL/6 mice orally challenged with H. pylori will be assessed for DC recruitment by FACS analysis. The role of CCR2 and tissue MCP-1 in DC recruitment will be studied using CCR2-/- mice and neutralization of MCP-1. 2. Dissect the steps in the DC-H. pylori interaction in vivo and in DC migration to secondary lymphoid organs. DCs from stomach associated lymph nodes of H. pylori-infected mice will be isolated FACS sorting and their reactivity against H.pylori will be assess by coculturing DCs with H. pylori-specific T cells from immune mice. In vivo trafficking of H. pylori via DC will be assessed by red fluorochrome-labeled H. pylori. 3. Determine the functional significance of DCs in H. pylori gastritis. Transgenic mice with diphtheria toxin-sensitive DCs will be used to assess the effect of transient DC depletion during acute and chronic H. pylori infection by administrating diphtheria toxin. The role of CCR2 in acute and chronic H. pylori gastritis will also be addressed using CCR2-/- mice. The health relatedness of the project is to understand the immune dysregulation that underlies H. pylori-induced chronic gastritis which may lead to novel targets or vaccine strategies for the prevention or treatment of emerging antibioticresistant H. pylori.
幽门螺杆菌是一种高适应性病原体,可逃避宿主细菌防御(即胃酸和体液免疫),导致慢性感染。这个提议的广泛的,长期的目标是阐明导致初始宿主免疫反应失败的因素,以根除幽门螺杆菌。提出的研究背后的具体假设是,针对急性幽门螺杆菌感染的dc依赖性适应性免疫机制存在缺陷

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN Y KAO其他文献

JOHN Y KAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN Y KAO', 18)}}的其他基金

Training in Basic and Translational Digestive Sciences
基础和转化消化科学培训
  • 批准号:
    10627226
  • 财政年份:
    2012
  • 资助金额:
    $ 13.21万
  • 项目类别:
Role of Dendritic Cells in H pylori-induced Treg-mediated Host Immune Tolerance
树突状细胞在幽门螺杆菌诱导的 Treg 介导的宿主免疫耐受中的作用
  • 批准号:
    8813558
  • 财政年份:
    2011
  • 资助金额:
    $ 13.21万
  • 项目类别:
Role of Dendritic Cells in H pylori-induced Treg-mediated Host Immune Tolerance
树突状细胞在幽门螺杆菌诱导的 Treg 介导的宿主免疫耐受中的作用
  • 批准号:
    8042112
  • 财政年份:
    2011
  • 资助金额:
    $ 13.21万
  • 项目类别:
Role of Dendritic Cells in H pylori-induced Treg-mediated Host Immune Tolerance
树突状细胞在幽门螺杆菌诱导的 Treg 介导的宿主免疫耐受中的作用
  • 批准号:
    8423787
  • 财政年份:
    2011
  • 资助金额:
    $ 13.21万
  • 项目类别:
Role of Dendritic Cells in H pylori-induced Treg-mediated Host Immune Tolerance
树突状细胞在幽门螺杆菌诱导的 Treg 介导的宿主免疫耐受中的作用
  • 批准号:
    8220843
  • 财政年份:
    2011
  • 资助金额:
    $ 13.21万
  • 项目类别:
Adaptive immune mechanism in acute H. pylori infection
急性幽门螺杆菌感染的适应性免疫机制
  • 批准号:
    7896313
  • 财政年份:
    2009
  • 资助金额:
    $ 13.21万
  • 项目类别:
The impact of Helicobacter pylori infection on inflammatory bowel disease suscept
幽门螺杆菌感染对炎症性肠病易感性的影响
  • 批准号:
    7511415
  • 财政年份:
    2008
  • 资助金额:
    $ 13.21万
  • 项目类别:
The impact of Helicobacter pylori infection on inflammatory bowel disease suscept
幽门螺杆菌感染对炎症性肠病易感性的影响
  • 批准号:
    7640537
  • 财政年份:
    2008
  • 资助金额:
    $ 13.21万
  • 项目类别:
Adaptive immune mechanism in acute H. pylori infection
急性幽门螺杆菌感染的适应性免疫机制
  • 批准号:
    7637483
  • 财政年份:
    2005
  • 资助金额:
    $ 13.21万
  • 项目类别:
Adaptive immune mechanism in acute H. pylori infection
急性幽门螺杆菌感染的适应性免疫机制
  • 批准号:
    7432592
  • 财政年份:
    2005
  • 资助金额:
    $ 13.21万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.21万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了